MA46997A - Préparation de complexes solides de cyclodextrine permettant une administration de substance pharmaceutique active ophtalmique - Google Patents

Préparation de complexes solides de cyclodextrine permettant une administration de substance pharmaceutique active ophtalmique

Info

Publication number
MA46997A
MA46997A MA046997A MA46997A MA46997A MA 46997 A MA46997 A MA 46997A MA 046997 A MA046997 A MA 046997A MA 46997 A MA46997 A MA 46997A MA 46997 A MA46997 A MA 46997A
Authority
MA
Morocco
Prior art keywords
preparation
active pharmaceutical
pharmaceutical substance
cyclodextrin complexes
allowing administration
Prior art date
Application number
MA046997A
Other languages
English (en)
Other versions
MA46997B1 (fr
Inventor
Zoltan Fulop
Thorsteinn Loftsson
Original Assignee
Oculis SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=61656066&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA46997(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Oculis SA filed Critical Oculis SA
Publication of MA46997A publication Critical patent/MA46997A/fr
Publication of MA46997B1 publication Critical patent/MA46997B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Optics & Photonics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA46997A 2016-11-29 2017-11-29 Préparation de complexes solides de cyclodextrine permettant une administration de substance pharmaceutique active ophtalmique MA46997B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662427737P 2016-11-29 2016-11-29
PCT/IB2017/001659 WO2018100434A1 (fr) 2016-11-29 2017-11-29 Préparation de complexes solides de cyclodextrine permettant une administration de substance pharmaceutique active ophtalmique

Publications (2)

Publication Number Publication Date
MA46997A true MA46997A (fr) 2019-10-09
MA46997B1 MA46997B1 (fr) 2022-01-31

Family

ID=61656066

Family Applications (1)

Application Number Title Priority Date Filing Date
MA46997A MA46997B1 (fr) 2016-11-29 2017-11-29 Préparation de complexes solides de cyclodextrine permettant une administration de substance pharmaceutique active ophtalmique

Country Status (30)

Country Link
US (6) US11135311B2 (fr)
EP (2) EP3548091B1 (fr)
JP (2) JP7138103B2 (fr)
KR (3) KR102525438B1 (fr)
CN (2) CN117018220A (fr)
AR (2) AR110270A1 (fr)
AU (1) AU2017369971B2 (fr)
CA (1) CA3045226A1 (fr)
CL (1) CL2019001447A1 (fr)
CO (1) CO2019005729A2 (fr)
CY (1) CY1124917T1 (fr)
DK (1) DK3548091T3 (fr)
EA (1) EA201991299A1 (fr)
ES (1) ES2903383T3 (fr)
HR (1) HRP20220046T1 (fr)
HU (1) HUE057221T2 (fr)
IL (2) IL310360A (fr)
LT (1) LT3548091T (fr)
MA (1) MA46997B1 (fr)
MD (1) MD3548091T2 (fr)
MX (1) MX2019006221A (fr)
PH (1) PH12019550088A1 (fr)
PL (1) PL3548091T3 (fr)
PT (1) PT3548091T (fr)
RS (1) RS62845B1 (fr)
SI (1) SI3548091T1 (fr)
TW (2) TWI773706B (fr)
UA (1) UA124774C2 (fr)
WO (1) WO2018100434A1 (fr)
ZA (1) ZA201903307B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI773706B (zh) * 2016-11-29 2022-08-11 瑞士商歐庫利斯公司 用於眼用活性藥物成分輸送的固體環糊精複合物之製備
IT201900000561A1 (it) * 2019-01-14 2020-07-14 Medivis S R L Formulazioni topiche oftalmiche chimicamente e fisicamente stabili a base di Nepafenac
CN110051859B (zh) * 2019-06-06 2020-06-12 鲁南制药集团股份有限公司 一种阿昔替尼环糊精包合物
EP3993807A1 (fr) 2019-07-01 2022-05-11 Oculis SA Procédé de stabilisation du ph d'une composition aqueuse comprenant un médicament
TWI756547B (zh) * 2019-07-15 2022-03-01 高雄榮民總醫院 奈米眼藥水及其製造方法
WO2022003037A1 (fr) * 2020-06-30 2022-01-06 Oculis SA Préparation de complexes de cyclodextrine solides pour l'administration de substance pharmaceutique active ophtalmique
CN111728953B (zh) * 2020-07-29 2023-08-08 中国科学院上海药物研究所 一种托法替布或其盐的缓释制剂及其制备方法
EP4282403A2 (fr) * 2021-01-21 2023-11-29 Taejoon Pharmaceutical Co., Ltd. Composition ophtalmique
US11998562B2 (en) * 2021-01-25 2024-06-04 University Of South Florida Ophthalmological formulations for the prevention of a coronavirus infection
WO2023132947A1 (fr) * 2022-01-05 2023-07-13 The Regents Of The University Of California Complexes de closo-dodécaiododécaborate et leurs procédés d'utilisation
AU2023214622A1 (en) 2022-02-02 2024-08-08 Oculis Operations Sarl Multidose ophthalmic compositions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5472954A (en) * 1992-07-14 1995-12-05 Cyclops H.F. Cyclodextrin complexation
EP0938896A1 (fr) 1998-01-15 1999-09-01 Novartis AG Compositions pharmaceutiques autoclavables contenant des agents de chelation
US20020198174A1 (en) * 2001-05-07 2002-12-26 Allergan Sales, Inc. Disinfecting and solubilizing steroid compositions
WO2002039993A2 (fr) * 2000-11-15 2002-05-23 Chandavarkar Mohan A Medicament combine
WO2004069280A1 (fr) 2003-02-06 2004-08-19 Cipla Ltd Complexes d'inclusion pharmaceutiques contenant un steroide et un agent antibacterien facultatif
CA2516429A1 (fr) * 2003-02-21 2004-10-14 Sun Pharmaceutical Industries Limited Composition ophtalmique stable
US7893040B2 (en) 2005-07-22 2011-02-22 Oculis Ehf Cyclodextrin nanotechnology for ophthalmic drug delivery
US20140163080A1 (en) * 2011-02-03 2014-06-12 Gnt, Llc Compositions and Methods for Treatment of Glaucoma
CN104411334A (zh) 2012-05-08 2015-03-11 欧尼斯治疗公司 用于配制肽蛋白酶体抑制剂的环糊精络合法
CA3050298A1 (fr) * 2012-08-24 2014-02-27 Sun Pharma Global Fze Formulation ophtalmique d'acide gras ou lipidique de polyoxyle et d'alcool de polyoxyethylene, et traitement de pathologies oculaires
TWI773706B (zh) * 2016-11-29 2022-08-11 瑞士商歐庫利斯公司 用於眼用活性藥物成分輸送的固體環糊精複合物之製備

Also Published As

Publication number Publication date
IL266964B1 (en) 2024-02-01
KR20230025939A (ko) 2023-02-23
AU2017369971A1 (en) 2019-06-13
CY1124917T1 (el) 2023-01-05
DK3548091T3 (da) 2022-01-17
PT3548091T (pt) 2022-01-21
US20190343846A1 (en) 2019-11-14
CN110177576A (zh) 2019-08-27
TWI773706B (zh) 2022-08-11
CN110177576B (zh) 2023-08-11
EA201991299A1 (ru) 2019-11-29
US11491240B2 (en) 2022-11-08
TW201825100A (zh) 2018-07-16
MX2019006221A (es) 2019-10-07
JP2022172291A (ja) 2022-11-15
KR20240036731A (ko) 2024-03-20
EP3548091A1 (fr) 2019-10-09
HRP20220046T1 (hr) 2022-04-15
AR110270A1 (es) 2019-03-13
CL2019001447A1 (es) 2019-08-09
AR110269A1 (es) 2019-03-13
US20240091377A1 (en) 2024-03-21
US20230042785A1 (en) 2023-02-09
KR20190091308A (ko) 2019-08-05
CA3045226A1 (fr) 2018-06-07
US11135311B2 (en) 2021-10-05
CN117018220A (zh) 2023-11-10
JP2019535798A (ja) 2019-12-12
IL266964B2 (en) 2024-06-01
PL3548091T3 (pl) 2022-03-28
PH12019550088A1 (en) 2020-06-15
JP7455917B2 (ja) 2024-03-26
ZA201903307B (en) 2020-09-30
US20180147297A1 (en) 2018-05-31
IL266964A (en) 2019-07-31
MA46997B1 (fr) 2022-01-31
SI3548091T1 (sl) 2022-04-29
TWI810167B (zh) 2023-08-01
JP7138103B2 (ja) 2022-09-15
KR102525438B1 (ko) 2023-04-26
MD3548091T2 (ro) 2022-03-31
CO2019005729A2 (es) 2019-08-30
US20230037486A1 (en) 2023-02-09
EP4194011A1 (fr) 2023-06-14
BR112019011067A2 (pt) 2019-12-17
UA124774C2 (uk) 2021-11-17
IL310360A (en) 2024-03-01
WO2018100434A1 (fr) 2018-06-07
ES2903383T3 (es) 2022-04-01
LT3548091T (lt) 2022-02-10
US20220008555A1 (en) 2022-01-13
TW201818943A (zh) 2018-06-01
EP3548091B1 (fr) 2021-12-01
HUE057221T2 (hu) 2022-04-28
AU2017369971B2 (en) 2023-06-01
RS62845B1 (sr) 2022-02-28

Similar Documents

Publication Publication Date Title
MA46997A (fr) Préparation de complexes solides de cyclodextrine permettant une administration de substance pharmaceutique active ophtalmique
MA52257A (fr) Compositions pharmaceutiques comprenant blautia et leur administration orale
MA45562A (fr) Préparation pharmaceutique liquide stable
MA42991A (fr) Stabilisation de compositions pharmaceutiques de camptothécine
EP3638248A4 (fr) Conjugués de principes pharmaceutiques actifs
MA41265A (fr) Compositions pour administration de médicaments iléo-jéjunal.
EP3524267A4 (fr) Traitement contre le cancer pharmacorésistant par administration d'un conjugué anticorps anti-her2/médicament
DK3727555T3 (da) Oral delivery of active drug substances
MA50541A (fr) Formulations pharmaceutiques
BR112016021012A2 (pt) composições farmacêuticas de compostos terapeuticamente ativos.
MA46867A (fr) Formulations pharmaceutiques
DK3378482T5 (da) Formulering til administration af antitumorlægemiddel
MA42303A (fr) Formulations pharmaceutiques
MX2017010280A (es) Complejos de acetato de abiraterona, proceso para la preparacion de los mismos y composiciones farmaceuticas que los contienen.
MA43705A (fr) Formulation pharmaceutique
MA42964A (fr) Préparation pharmaceutique anti-vieillissement
CY1121105T1 (el) Φαρμακοτεχνικη μορφη αταζαναβιρης και κομπισιστατης για θεραπεια hiv
MA52704A (fr) Préparation pharmaceutique
EP2981258B8 (fr) Formulations pharmaceutiques pour l'administration sous-cutanée de furosémide
MA49837A (fr) Compositions pharmaceutiques
EP3253372B8 (fr) Préparation d'une émulsion huile dans l'eau pour formulations pharmaceutiques stabilisées par un polymère
IL260766B (en) Continuous production of complexes containing active pharmaceutical ingredients
EP3373909A4 (fr) Formulations d'émulsion lipidique enrichie en vitamine k pour le traitement de la toxicité pharmaceutique
DK3773595T3 (da) Farmaceutiske anticancer-sammensætninger til kombineret terapi
MA46759A (fr) Dosage de conjugués anticorps-médicament anti-cd30 pour humain non adulte